Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinoma.

about

The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis.

P2860

Q52727884-A259F473-666F-4BD4-9DF8-8E40EBDB33D8

P2860

Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinoma.

Item

http://www.wikidata.org/entity/Q40979380

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pirfenidone may revert the epi ...... in human lung adenocarcinoma.

@en

type

Item

label

Pirfenidone may revert the epi ...... in human lung adenocarcinoma.

@en

prefLabel

Pirfenidone may revert the epi ...... in human lung adenocarcinoma.

@en

P1476

Pirfenidone may revert the epi ...... in human lung adenocarcinoma.

@en

P2093

Koichiro Tatsumi

http://www.w3.org/2001/XMLSchema#string

Ryota Kurimoto

http://www.w3.org/2001/XMLSchema#string

Shunichiro Iwasawa

http://www.w3.org/2001/XMLSchema#string

Takahiro Ebata

http://www.w3.org/2001/XMLSchema#string

Tsukasa Ishiwata

http://www.w3.org/2001/XMLSchema#string

Yuichi Takiguchi

http://www.w3.org/2001/XMLSchema#string

Yuji Tada

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Epithelial-mesenchymal transitions in development and disease

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

Pirfenidone in idiopathic pulmonary fibrosis

TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition

Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway

Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis.

In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion.

Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production.

P304

944-950

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.6188

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28693256

http://www.w3.org/2001/XMLSchema#string

P932

5494670

http://www.w3.org/2001/XMLSchema#string

Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinoma.

about

P2860

P2860

Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932